A study of circulating anti-CD25 antibodies in non-small cell lung cancer

Clinical and Translational Oncology

Volumn 15, Issue 8, 2013, Pages 633-637

  Ye, L ^a   Li, X ^a   Sun, S ^b   Guan, S ^b   Wang, M ^a   Guan, X ^a   Lee, K H ^c   Wei, J ^d   Liu, B ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

^c Pei Ling Guan Si Hospital   (Taiwan)

^d UNIVERSITY OF THE HIGHLANDS AND ISLANDS   (United Kingdom)

Author keywords

Autoantibody; Biomarker; CD25; Lung cancer; Tumor immunity

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; TUMOR MARKER; ANTI-IGG; ANTIIDIOTYPIC ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE DYSREGULATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; REGULATORY T LYMPHOCYTE; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; TUMOR IMMUNITY; UPREGULATION; BLOOD; IMMUNOLOGY; LUNG TUMOR; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY;

ANTIBODIES, ANTI-IDIOTYPIC; CARCINOMA, NON-SMALL-CELL LUNG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84880275856     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0980-2     Document Type: Article

References (25)

1. Reuschenbach M, von Knebel Doeberitz M, Wentzensen N (2009) A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother 58:1535-1544
2. Kobold S, Lütkens T, Cao Y, Bokemeyer C, Atanackovic D (2010) Autoantibodies against tumor-related antigens: incidence and biologic significance. Hum Immunol 71:643-651
3. Järås K, Anderson K (2011) Autoantibodies in cancer: prognostic biomarkers and immune activation. Expert Rev Proteomics 8:577-589
4. Liu W, Peng B, Lu Y, Xu W, Qian W, Zhang J-Y (2011) Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev 10:331-335
5. Piura E, Piura B (2010) Autoantibodies to tumor-associated antigens in breast carcinoma. J Oncol 2010:264926 (Epub)
6. Piura E, Piura B (2011) Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma. J Oncol 2011:982425 (Epub)
7. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, Hirschowitz EA (2006) Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 1:513-519 (Pubitemid 47181397)
8. Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, Barnes A, Robertson J (2007) Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18:868-873 (Pubitemid 47054083)
9. Tan HT, Low J, Lim SG, Chung MC (2009) Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276:6880-6904
10. Lam S, Boyle P, Healey GF, Maddison P, Peek L, Murray A, Chapman CJ, Allen J, Wood WC, Sewell HF, Robertson JF (2011) EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 4:1126-1134
11. Soussi T (2011) TP53 mutations in human cancer: database reassessment and prospects for the next decade. Adv Cancer Res 110:107-139
12. Chen YT, Scanlan MJ, Sahin U, Türeci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914-1918 (Pubitemid 27113936)
13. Schubert U, Antón LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770-774 (Pubitemid 30212405)
14. Ulanet DB, Torbenson M, Dang CV, Casciola-Rosen L, Rosen A (2003) Unique conformation of cancer autoantigen B23 in hepatoma: a mechanism for specificity in the autoimmune response. Proc Natl Acad Sci USA 100:12361-12366 (Pubitemid 37271565)
15. Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z (2011) Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 10:744-755
16. Redpath M, Xu B, van Kempen LC, Spatz A (2011) The dual role of the X-linked FoxP3 gene in human cancers. Mol Oncol 5:156-163
17. + T cells to T-regulatory cells. Cancer Res 71:3505-3515
18. Wang YY, He XY, Cai YY, Wang ZJ, Lu SH (2011) The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN. Target Oncol 6:147-154
19. Xu T, Duan Q, Wang G, Hu B (2011) CD4 + CD25high regulatory T cell numbers and FOXP3 mRNA expression in patients with advanced esophageal cancer before and after chemotherapy. Cell Biochem Biophys 61:389-392
20. Erfani N, Mehrabadi SM, Ghayumi MA, Haghshenas MR, Mojtahedi Z, Ghaderi A, Amani D (2012) Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung Cancer 77:306-311
21. Söllner J, Heinzel A, Summer G, Fechete R, Stipkovits L, Szathmary S, Mayer B (2010) Concept and application of a computational vaccinology workflow. Immunome Res 6(Suppl 2):S7
22. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, Peters B (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11:568 (Epub)
23. Liu L, Liu N, Liu B, Yang Y, Zhang Q, Zhang W, Yu P, Jin Y, Guo J, Guan S, Sun S, Miao L, Wei J (2012) Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? J Cancer Res Clin Oncol 138:1737-1742
24. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133:775-787 (Pubitemid 351707693)
25. + regulatory T cells. Nat Immunol 4:330-336 (Pubitemid 36432314)